Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy AdultsAlexander Rodero-Romero, Luisa María Villar, Fernando Rodríguez‐Jorge et al.|International Journal of Molecular Sciences|2024Cited by 20
Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis PatientsRaquel Sainz-Amo, Luisa María Villar, Alexander Rodero-Romero et al.|International Journal of Molecular Sciences|2024Cited by 10
Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple SclerosisEnric Monreal, Luisa María Villar, José Ignacio Fernández-Velasco et al.|International Journal of Molecular Sciences|2025Cited by 5
Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosisAlexander Rodero-Romero, Luisa María Villar, José Ignacio Fernández-Velasco et al.|Frontiers in Immunology|2025Cited by 1